Overview

Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
To demonstrate improved subjective sleep in women with insomnia secondary to perimenopause or menopause following treatment with 3 mg of eszopiclone.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Eszopiclone
Zopiclone